Clover Health Investments Gross Profit 2020-2023 | CLOV

Clover Health Investments gross profit from 2020 to 2023. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
Clover Health Investments Annual Gross Profit
(Millions of US $)
2023 $257
2022 $23
2021 $-79
2020 $83
2019 $16
Clover Health Investments Quarterly Gross Profit
(Millions of US $)
2023-12-31 $62
2023-09-30 $63
2023-06-30 $77
2023-03-31 $55
2022-12-31 $5
2022-09-30 $17
2022-06-30 $-12
2022-03-31 $13
2021-12-31 $-10
2021-09-30 $-9
2021-06-30 $-46
2021-03-31 $-14
2020-12-31 $-13
2020-09-30 $24
2020-06-30 $53
2020-03-31 $19
2019-12-31
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.344B $2.034B
Clover Health Investments Corp. is a healthcare technology company. It uses its proprietary technology platform to collect, structure and analyze health and behavioral data to improve medical outcomes and lower costs for patients. Clover Health Investments Corp., formerly known as Social Capital Hedosophia Holdings Corp. III, is based in Calif.
Stock Name Country Market Cap PE Ratio
GE HealthCare Technologies (GEHC) United States $36.275B 19.92
Inspire Medical Systems (INSP) United States $7.566B 0.00
Axonics (AXNX) United States $3.433B 0.00
10x Genomics (TXG) United States $3.275B 0.00
IRhythm Technologies (IRTC) United States $3.194B 0.00
Azenta (AZTA) United States $2.979B 242.82
Olink Holding AB (publ) (OLK) Sweden $2.861B 0.00
Enovis (ENOV) United States $2.812B 20.84
Hims & Hers Health (HIMS) United States $2.412B 0.00
Privia Health (PRVA) United States $2.224B 98.63
Schrodinger (SDGR) United States $1.712B 0.00
Omnicell (OMCL) United States $1.384B 47.83
Phreesia (PHR) United States $1.259B 0.00
Definitive Healthcare (DH) United States $0.828B 0.00
Standard BioTools (LAB) United States $0.728B 0.00
Fulgent Genetics (FLGT) United States $0.643B 0.00
Talkspace (TALK) United States $0.538B 0.00
Health Catalyst (HCAT) United States $0.383B 0.00
Pulmonx (LUNG) United States $0.378B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.326B 0.00
P3 Health Partners (PIII) United States $0.202B 0.00
Butterfly Network (BFLY) United States $0.196B 0.00
American Well (AMWL) United States $0.165B 0.00
Outset Medical (OM) United States $0.162B 0.00
Augmedix (AUGX) United States $0.133B 0.00
MSP Recovery (LIFW) United States $0.125B 0.00
TruBridge (TBRG) United States $0.125B 5.33
Mobile-health Network Solutions (MNDR) Singapore $0.108B 0.00
111 (YI) China $0.096B 0.00
Future Health ESG (FHLT) United States $0.071B 0.00
SHL Telemedicine (SHLT) Israel $0.068B 0.00
HeartBeam (BEAT) United States $0.058B 0.00
Zepp Health (ZEPP) China $0.053B 0.00
Movano (MOVE) United States $0.046B 0.00
EUDA Health Holdings (EUDA) Singapore $0.044B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.034B 0.00
Akili (AKLI) United States $0.032B 0.00
Bullfrog AI Holdings (BFRG) United States $0.024B 0.00
Cue Health (HLTH) United States $0.022B 0.00
Streamline Health Solutions (STRM) United States $0.019B 0.00
CareCloud (CCLD) United States $0.018B 0.00
ETAO (ETAO) United States $0.016B 0.00
Strata Skin Sciences (SSKN) United States $0.015B 0.00
Biotricity (BTCY) United States $0.012B 0.00
Transgenomic (PRPO) United States $0.009B 0.00
Syra Health (SYRA) United States $0.008B 0.00
Predictive Oncology (POAI) United States $0.007B 0.00
Healthcare Triangle (HCTI) United States $0.006B 0.00
HeartSciences (HSCS) United States $0.006B 0.00
Zhongchao (ZCMD) China $0.003B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
Centogene (CNTG) Germany $0.000B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00